Pharma Journalist -

DePuy Synthes, a leader in orthopedic technologies and part of Johnson & Johnson MedTech, has announced the U.S. commercial launch of VELYS™ Hip Navigation with AI Assistance, a…
Read More...

Eli Lilly and Company has launched a new national awareness campaign featuring basketball legend Shaquille O’Neal to spotlight moderate-to-severe obstructive sleep apnea (OSA), a common…
Read More...

Bayer has reached an important regulatory milestone for its investigational stroke prevention therapy as the European Medicines Agency (EMA) has validated and begun reviewing the…
Read More...

Beren Therapeutics P.B.C. has raised $300 million in combined financing to support the development and potential commercialization of its investigational therapy adrabetadex, a…
Read More...

GSK has agreed to acquire clinical-stage biotechnology company Nuvalent for approximately $10.6 billion, strengthening its oncology portfolio with a trio of targeted lung cancer…
Read More...

Aditxt, Inc. has announced a definitive business combination agreement that will enable its wholly owned subsidiary, Ignite Proteomics, to become an independent publicly traded company…
Read More...

Eli Lilly and Company has received approval from the U.S. Food and Drug Administration (FDA) for an expanded dosing schedule of EBGLYSS® (lebrikizumab-lbkz), allowing eligible patients…
Read More...

Pfizer has secured an expanded approval from the U.S. Food and Drug Administration (FDA) for HYMPAVZI® (marstacimab-hncq), broadening access to the once-weekly treatment for additional…
Read More...

Johnson & Johnson has agreed to acquire biotechnology company Firefly Bio, Inc. in a deal valued at $1 billion in cash, strengthening its oncology pipeline with a novel platform…
Read More...

Incyte has announced a definitive agreement to acquire Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, in a deal valued at $1.25 billion upfront, with the potential…
Read More...